Laihinen AO - Search Results

1

Striatal [18F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson's disease.

Ruottinen HM, Rinne JO, Ruotsalainen UH, Bergman JR, Oikonen VJ, Haaparanta MT, Solin OH, Laihinen AO, Rinne UK. Ruottinen HM, et al. Among authors: laihinen ao. J Neural Transm Park Dis Dement Sect. 1995;10(2-3):91-106. doi: 10.1007/BF02251225. J Neural Transm Park Dis Dement Sect. 1995. PMID: 9620057 Clinical Trial.

2

PET studies on brain monoamine transporters with carbon-11-beta-CIT in Parkinson's disease.

Laihinen AO, Rinne JO, Någren KA, Lehikoinen PK, Oikonen VJ, Ruotsalainen UH, Ruottinen HM, Rinne UK. Laihinen AO, et al. J Nucl Med. 1995 Jul;36(7):1263-7. J Nucl Med. 1995. PMID: 7790953 Free article.

3

PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756.

Laihinen AO, Rinne JO, Ruottinen HM, Någren KA, Lehikoinen PK, Oikonen VJ, Ruotsalainen UH, Rinne UK. Laihinen AO, et al. J Nucl Med. 1994 Dec;35(12):1916-20. J Nucl Med. 1994. PMID: 7989969 Free article. Clinical Trial.

4

Positron emission tomography of brain dopamine D-1 receptors with 11C-SCH 23390 in Parkinson's disease.

Rinne JO, Laihinen A, Någren K, Bergman J, Haaparanta M, Solin O, Ruotsalainen U, Rinne UK. Rinne JO, et al. Acta Radiol Suppl. 1991;376:152. Acta Radiol Suppl. 1991. PMID: 1666760 No abstract available.

5

[18F]-6-fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR-462).

Laihinen A, Rinne JO, Rinne UK, Haaparanta M, Ruotsalainen U, Bergman J, Solin O. Laihinen A, et al. Neurology. 1992 Jan;42(1):199-203. doi: 10.1212/wnl.42.1.199. Neurology. 1992. PMID: 1734304

6

A post-mortem study on striatal dopamine receptors in Parkinson's disease.

Rinne JO, Laihinen A, Lönnberg P, Marjamäki P, Rinne UK. Rinne JO, et al. Brain Res. 1991 Aug 9;556(1):117-22. doi: 10.1016/0006-8993(91)90554-9. Brain Res. 1991. PMID: 1834312

7

PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease.

Rinne JO, Laihinen A, Någren K, Bergman J, Solin O, Haaparanta M, Ruotsalainen U, Rinne UK. Rinne JO, et al. J Neurosci Res. 1990 Dec;27(4):494-9. doi: 10.1002/jnr.490270409. J Neurosci Res. 1990. PMID: 1981915

8

Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease.

Rinne UK, Laihinen A, Rinne JO, Någren K, Bergman J, Ruotsalainen U. Rinne UK, et al. Mov Disord. 1990;5(1):55-9. doi: 10.1002/mds.870050114. Mov Disord. 1990. PMID: 2136932

9

Striatal kinetics of [11C]-(+)-nomifensine and 6-[18F]fluoro-L-dopa in Parkinson's disease measured with positron emission tomography.

Tedroff J, Aquilonius SM, Laihinen A, Rinne U, Hartvig P, Anderson J, Lundqvist H, Haaparanta M, Solin O, Antoni G, et al. Tedroff J, et al. Acta Neurol Scand. 1990 Jan;81(1):24-30. doi: 10.1111/j.1600-0404.1990.tb00926.x. Acta Neurol Scand. 1990. PMID: 2330812

10

Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors.

Rinne JO, Hublin C, Partinen M, Ruottinen H, Ruotsalainen U, Någren K, Lehikoinen P, Laihinen A. Rinne JO, et al. Neurology. 1995 Sep;45(9):1735-8. doi: 10.1212/wnl.45.9.1735. Neurology. 1995. PMID: 7675236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters